For Rs 628 crore JB Chemicals to buy brands from Sanzyme


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
With Rs 628 crore, the board of JB Chemicals will acquire a bunch of brands from Sanzyme Private Limited (SPL).

With Rs 628 crore, the board of JB Chemicals will acquire a bunch of brands from Sanzyme Private Limited (SPL). The brands in question are Sporlac, Oxalo, Lobun, Nano-Leo and Gynogen. 

Sporlac is India’s third-largest probiotics brand. Oxalo is a risk-free therapy that can decalcify kidney stones. Whereas, Lobun can delay the progression of chronic kidney diseases. The brands have a reach of 3 lakh chemists and 1 lakh prescribers. 

Nano Leo is a pro-sexual nutrient formulation for libido, erection, and orgasm in patients with erectile dysfunction. Gynogen stimulates the growth and recruitment of immature ovarian follicles in the ovary and is routinely used as a part of Assisted Reproductive Technology.

The turnover of these brands in FY20-21 was Rs 88 crores and for FY21-22 it was Rs 75 crores. The deal will mark JB Chemicals' entry into a range of sectors like probiotics, therapeutic nutraceuticals and reproductive health. 

The deal will close next month and is the first acquisition of JB Chemicals. JB Chemicals will scale up these brands pan-India. The brands will also gain immense visibility using JB Chemicals distribution network. 

They are a profitable business whose net profit in the quarter ended in September 2021 was Rs 97.88 crore. Citing IQVIA MAT December 2021 data, JBCPL said the revenue for the combined brands was Rs 160 crore.

Tags : #JBChemicals #Sanzyme #Sporlac #Oxalo #Lobun #Nano-Leo #Gynogen #funding #acquisition #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026